Sakano I, Ishii T, Ichikawa S, Harasawa K, Minohara K, Yamamura S, Nishiyama S
Parke-Davis Research Laboratory, Warner-Lambert K.K., Kanagawa, Japan.
J Pharm Sci. 1994 Sep;83(9):1363-6. doi: 10.1002/jps.2600830931.
Column chromatography, thin-layer chromatography, high-performance liquid chromatography, nuclear magnetic resonance spectrometry, and high-resolution mass spectrometry were employed to separate and identify the photodegradation products of pirmenol hydrochloride [(+/-)-cis-alpha-[3-(2,6-dimethyl-1-piperidinyl)propyl]-alpha-phenyl-2- pyridinemethanol monohydrochloride monohydrate], a new antiarrhythmic drug. A methanol solution of pirmenol was irradiated using a low-pressure mercury lamp. The solution afforded four major degradation products, three of which were identified as 3-(cis-2,6-dimethylpiperidinyl)propyl 2-(2-pyridyl)phenyl ketone, 2-(2-pyridyl)benzoic acid, and methyl 2-(2-pyridyl)-benzoate. The degradation followed apparent-first-order reaction kinetics. In addition, the possible photodegradation pathways are discussed with reference to reaction mechanisms.
采用柱色谱法、薄层色谱法、高效液相色谱法、核磁共振光谱法和高分辨质谱法对新型抗心律失常药物盐酸吡美诺[(±)-顺-α-[3-(2,6-二甲基-1-哌啶基)丙基]-α-苯基-2-吡啶甲醇一水合盐酸盐]的光降解产物进行分离和鉴定。用低压汞灯照射吡美诺的甲醇溶液。该溶液产生了四种主要降解产物,其中三种被鉴定为3-(顺-2,6-二甲基哌啶基)丙基2-(2-吡啶基)苯基酮、2-(2-吡啶基)苯甲酸和2-(2-吡啶基)苯甲酸甲酯。降解遵循表观一级反应动力学。此外,还参照反应机理讨论了可能的光降解途径。